ArticleJournal of clinical and translational science2026
Flexible outlier detection in multicenter clinical trials.
Article in Journal of clinical and translational science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Multicenter clinical trials have become increasingly larger and more complex yet assuring high-quality data remains an essential task for data coordinating centers. Methods: A flexible algorithm is presented to exhaustively search for potential data anomalies by participant and site. The algorithm proceeds as a three-phase collaboration between the data coordinating center and clinical sites. First, participant-level data are examined in a univariate approach for all relevant variables. Values at the extreme tails of the distribution that also lie outside range checks and are previously unverified by clinical sites are deemed potential outliers. Second, participant-level data are examined in a multivariate machine learning approach among meaningful groups of related variables, Results: Application of the algorithm to MoTrPAC yielded an evaluation of over 1.9 million observations in Conclusion: It is recommended to apply this algorithm to a subset of participants early in a study, with repeated explorations over subsequent intervals throughout the study. The goal is to maximize data quality, particularly critical to the increasing occurrence of open-source, data resources.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.